Ap. Pharmamax
0434.458.941 · rovalta.com · 09/11/2026
Ap. Pharmamax
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOAp. Pharmamax is a Private company with limited liability incorporated in 1988. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Boom.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0434.458.941
- Incorporation
- 04/06/1988
- Legal form
- Private company with limited liability
- Registered office
- Peter Benoitstraat 46
2850 Boom · FlandreSee on map - Contributed capital
- 25 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 0,0 ETP
Joint committees (1)
- 313
Financials
Source · NBB, 21 filingsTrend over 15 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 184 k € | -47.9% | 353,4 k € | -4.1% | 368,4 k € | +2.0% | 361,2 k € | +12.9% | 320 k € |
| EBITDA | 182,2 k € | -43.7% | 323,9 k € | -6.5% | 346,5 k € | +5.5% | 328,3 k € | +14.5% | 286,8 k € |
| Operating result | 171,7 k € | -45.0% | 312 k € | -6.1% | 332,2 k € | +3.8% | 320,1 k € | +17.5% | 272,4 k € |
| Net result | 130,7 k € | -55.0% | 290,2 k € | -10.2% | 323 k € | +45.3% | 222,4 k € | +18.1% | 188,3 k € |
| Balance sheet | |||||||||
| Equity | 377,7 k € | +7.9% | 350 k € | +0.1% | 349,8 k € | +7.0% | 326,8 k € | +213% | 104,4 k € |
| Total assets | 1,1 M € | +7.4% | 1 M € | +18.6% | 851,8 k € | +48.7% | 572,9 k € | +25.8% | 455,5 k € |
| Cash | 549,6 k € | +54.6% | 355,5 k € | +3.5% | 343,5 k € | +47.7% | 232,5 k € | +117% | 106,9 k € |
| Debts | 707,5 k € | +7.2% | 660,1 k € | +58.9% | 415,4 k € | +68.8% | 246,1 k € | -29.8% | 350,4 k € |
| Other | |||||||||
| Workforce | 0,0 ETP | -100% | 0,8 ETP | 0.0% | 0,8 ETP | 0,0 ETP | -100% | 0,8 ETP | |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 4 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 01/09/2015Manager01/09/2015 → 2018 accountsended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Pharmagrex NV | Bestuurder01/09/2015 → 2021 accounts | ||
Filip Baute | Manager20/11/2013 → 2014 accounts | ||
Steven Meuleman | Manager01/07/2008 → 2014 accounts | ||
Mari-Rose Vogelaers | Manager2007 accounts |
Other companies at this address
Peter Benoitstraat 46 2850 Boom| Company | CBE no. |
|---|---|
Pharmagrex● Active | 0635.846.678 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/09/2026 | 04/09/2025 | 17/12/2024 | 18/12/2023 | 29/09/2022 | 17/08/2021 |
| General meeting | 30/06/2026 | 30/06/2025 | 30/06/2024 | 30/06/2023 | 03/06/2022 | 04/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 21 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 30/06/2026 | 29/09/2026 | Dutch | |
| Abridged model | 31/12/2024 | 30/06/2025 | 04/09/2025 | Dutch | |
| Abridged model | 31/12/2023 | 30/06/2024 | 17/12/2024 | Dutch | |
| Abridged model | 31/12/2022 | 30/06/2023 | 18/12/2023 | Dutch | |
| Abridged model | 31/12/2021 | 03/06/2022 | 29/09/2022 | Dutch | |
| Abridged model | 31/12/2020 | 04/06/2021 | 17/08/2021 | Dutch | |
| Abridged model | 31/12/2019 | 05/06/2020 | 29/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 07/06/2019 | 19/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 01/06/2018 | 26/07/2018 | Dutch | |
| Abridged model | 31/12/2016 | 02/06/2017 | 08/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 03/06/2016 | 22/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 05/06/2015 | 24/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 06/06/2014 | 30/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 07/06/2013 | 22/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 01/06/2012 | 17/07/2012 | Dutch | |
| Abridged model | 31/12/2010 | 03/06/2011 | 21/07/2011 | Dutch | |
| Abridged model | 30/06/2010 | 24/09/2010 | 18/01/2011 | Dutch | |
| Abridged model | 30/06/2009 | 25/09/2009 | 05/02/2010 | Dutch | |
| Abridged model | 30/06/2008 | 26/09/2008 | 23/12/2008 | Dutch | |
| Abridged model | 31/12/2007 | 30/05/2008 | 15/07/2008 | Dutch | |
| Abridged model | 31/12/2006 | 25/05/2007 | 29/06/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 4 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Directorsince 01/09/2015Manager01/09/2015 → 2018 accountsended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Pharmagrex NV | Bestuurder01/09/2015 → 2021 accounts | ||
Filip Baute | Manager20/11/2013 → 2014 accounts | ||
Steven Meuleman | Manager01/07/2008 → 2014 accounts | ||
Mari-Rose Vogelaers | Manager2007 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates13/10/2015Naamwijziging — Statutenwijzigingen — Ontslag van de statutaire :
- Mandates03/12/2013benoeming statutair zaakvoerder
- Mandates01/10/2010ONTSLAGEN - BENOEMINGEN - BOEKJAAR
- Mandates20/06/2008ONTSLAGEN - BENOEMINGEN - BOEKJAAR
- Capital / shares19/09/2007Buitengewone algemene vergadering — Kapitaalvermindering-
- Capital / shares16/10/2006| KAPITAALVERHOGING - OMZETTING VAN HET KAPITAAL IN EURO STATUTENWIJZIGING
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Peter Benoitstraat 46, 2850 BoomCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00547893 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Ap. PharmamaxCurrent | accounts 2022 → 2025 | Accounts 2025 · 2026-00547893 |
| Pharmamax BVBA | accounts 2021 | Accounts 2021 · 2022-20439554 |
Events
- 2025Annual accounts 2025130,7 k €↓
- 2024Annual accounts 2024290,2 k €↓
- 2023Annual accounts 2023323 k €↑
- 2022Annual accounts 2022222,4 k €↑
- 2022Name changeAp. Pharmamax
- 2021Annual accounts 2021188,3 k €↑
- 2014Annual accounts 2014-27,9 k €↑
- 2013Annual accounts 2013-156,5 k €↓
- 2012Annual accounts 2012-56,2 k €↑
- 2011Annual accounts 2011-64,3 k €↓
- 2010Annual accounts 201030,5 k €↑
- 2010Annual accounts 2010-5,4 k €↑
- 2009Annual accounts 2009-7,9 k €↓
- 2008Annual accounts 20086,7 k €↓
- 2007Annual accounts 200715,9 k €↑
- 2006Annual accounts 2006-22,2 k €
- 04/06/1988IncorporationPrivate company with limited liability